BlackRock Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.43M | Sell |
675,286
-9,810
| -1% | -$20.8K | ﹤0.01% | 2448 |
|
|
2016
Q3 | $2.3M | Sell |
685,096
-2,882
| -0.4% | -$9.65K | ﹤0.01% | 2043 |
|
|
2016
Q2 | $2.16M | Buy |
687,978
+72,358
| +12% | +$227K | ﹤0.01% | 2032 |
|
|
2016
Q1 | $2.05M | Buy |
615,620
+662
| +0.1% | +$2.2K | ﹤0.01% | 1988 |
|
|
2015
Q4 | $2.18M | Buy |
614,958
+1,716
| +0.3% | +$6.08K | ﹤0.01% | 2014 |
|
|
2015
Q3 | $3.09M | Buy |
613,242
+3,816
| +0.6% | +$19.2K | ﹤0.01% | 1725 |
|
|
2015
Q2 | $3.92M | Buy |
609,426
+162,302
| +36% | +$1.04M | ﹤0.01% | 1692 |
|
|
2015
Q1 | $3.15M | Buy |
447,124
+6,947
| +2% | +$48.9K | ﹤0.01% | 1714 |
|
|
2014
Q4 | $3.39M | Sell |
440,177
-2,303
| -0.5% | -$17.8K | ﹤0.01% | 1654 |
|
|
2014
Q3 | $3.31M | Buy |
442,480
+3,279
| +0.7% | +$24.5K | ﹤0.01% | 1630 |
|
|
2014
Q2 | $4.25M | Sell |
439,201
-4,789
| -1% | -$46.4K | 0.01% | 1506 |
|
|
2014
Q1 | $3.69M | Buy |
443,990
+56,000
| +14% | +$465K | 0.01% | 1589 |
|
|
2013
Q4 | $3.28M | Sell |
387,990
-10,603
| -3% | -$89.5K | ﹤0.01% | 1650 |
|
|
2013
Q3 | $3.18M | Buy |
398,593
+26,489
| +7% | +$211K | 0.01% | 1599 |
|
|
2013
Q2 | $2.87M | Buy |
+372,104
| New | +$2.87M | 0.01% | 1581 |
|